Founded in 2002, Aptus Endosystems has created a unique endograft and endovascular stapling system that offers a durable alternative to open surgical repair. Their innovative helical staple technology allows for independent endograft fixation, providing a low profile delivery with no structural compromises. This enables surgeons to treat abdominal aortic aneurysms through a minimally invasive approach while still maintaining control similar to an open surgical repair. The company's products have received CE Marking for distribution in the European Union and FDA clearance for distribution in the United States. Aptus Endosystems focuses on developing next-generation endograft devices, delivery systems, and fixation technology for the treatment of Abdominal Aortic Aneurysms.